Literature DB >> 16849426

Human prions and plasma lipoproteins.

Jiri G Safar1, Holger Wille, Michael D Geschwind, Camille Deering, Diane Latawiec, Ana Serban, David J King, Giuseppe Legname, Karl H Weisgraber, Robert W Mahley, Bruce L Miller, Stephen J Dearmond, Stanley B Prusiner.   

Abstract

Prions are composed solely of an alternatively folded isoform of the prion protein (PrP), designated PrP(Sc). The polyoxometalate phosphotungstic acid has been used to separate PrP(Sc) from its precursor PrP(C) by selective precipitation; notably, native PrP(Sc) has not been solubilized by using nondenaturing detergents. Because of the similarities between PrP(Sc) and lipoproteins with respect to hydrophobicity and formation of phosphotungstic acid complexes, we asked whether these molecules are bound to each other in blood. Here we report that prions from the brains of patients with sporadic Creutzfeldt-Jakob disease (CJD) bind to very low-density (VLDL) and low-density (LDL) lipoproteins but not to high-density lipoproteins (HDL) or other plasma components, as demonstrated both by affinity assay and electron microscopy. Immunoassays demonstrated that apolipoprotein B (apoB), which is the major protein component of VLDL and LDL, bound PrP(Sc) through a highly cooperative process. Approximately 50% of the PrP(Sc) bound to LDL particles was released after exposure to 4 M guanidine hydrochloride at 80 degrees C for 20 min. The apparent binding constants of native human (Hu) PrP(Sc) or denatured recombinant HuPrP(90-231) for apoB and LDL ranged from 28 to 212 pM. Whether detection of PrP(Sc) in VLDL and LDL particles can be adapted into an antemortem diagnostic test for prions in the blood of humans, livestock, and free-ranging cervids remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849426      PMCID: PMC1544083          DOI: 10.1073/pnas.0604021103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes.

Authors:  R H Kimberlin; C A Walker
Journal:  J Comp Pathol       Date:  1979-10       Impact factor: 1.311

2.  Partial purification and evidence for multiple molecular forms of the scrapie agent.

Authors:  S B Prusiner; W J Hadlow; D E Garfin; S P Cochran; J R Baringer; R E Race; C M Eklund
Journal:  Biochemistry       Date:  1978-11-14       Impact factor: 3.162

3.  Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

Authors:  Luisa Gregori; Nancy McCombie; Douglas Palmer; Paul Birch; Samuel O Sowemimo-Coker; Antonio Giulivi; Robert G Rohwer
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

4.  Selective precipitation of prions by polyoxometalate complexes.

Authors:  In Su Lee; Jeffrey R Long; Stanley B Prusiner; Jiri G Safar
Journal:  J Am Chem Soc       Date:  2005-10-12       Impact factor: 15.419

5.  Pathogenesis of scrapie virus infection in the mouse.

Authors:  C M Eklund; R C Kennedy; W J Hadlow
Journal:  J Infect Dis       Date:  1967-02       Impact factor: 5.226

6.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.

Authors:  Gianluca Moroncini; Nnennaya Kanu; Laura Solforosi; Gil Abalos; Glenn C Telling; Mark Head; James Ironside; Jeremy P Brockes; Dennis R Burton; R Anthony Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

Authors:  David A Hilton; Azra C Ghani; Lisa Conyers; Philip Edwards; Linda McCardle; Diane Ritchie; Mark Penney; Doha Hegazy; James W Ironside
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

Review 9.  Lipid disorders and mutations in the APOB gene.

Authors:  Amanda J Whitfield; P Hugh R Barrett; Frank M van Bockxmeer; John R Burnett
Journal:  Clin Chem       Date:  2004-08-12       Impact factor: 8.327

10.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

Authors:  Alexander H Peden; Mark W Head; Diane L Ritchie; Jeanne E Bell; James W Ironside
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

View more
  17 in total

1.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

Review 2.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  The physical relationship between infectivity and prion protein aggregates is strain-dependent.

Authors:  Philippe Tixador; Laëtitia Herzog; Fabienne Reine; Emilie Jaumain; Jérôme Chapuis; Annick Le Dur; Hubert Laude; Vincent Béringue
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

Review 4.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

5.  Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection.

Authors:  M Michal Peterson; Jessica L Mack; Pamela R Hall; Anny A Alsup; Susan M Alexander; Erin K Sully; Youhanna S Sawires; Ambrose L Cheung; Michael Otto; Hattie D Gresham
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

6.  Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection.

Authors:  Tracy Haldiman; Chae Kim; Yvonne Cohen; Wei Chen; Janis Blevins; Liuting Qing; Mark L Cohen; Jan Langeveld; Glenn C Telling; Qingzhong Kong; Jiri G Safar
Journal:  J Biol Chem       Date:  2013-08-23       Impact factor: 5.157

7.  Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders.

Authors:  Rocco Adiutori; Fabiola Puentes; Michael Bremang; Vittoria Lombardi; Irene Zubiri; Emanuela Leoni; Johan Aarum; Denise Sheer; Simon McArthur; Ian Pike; Andrea Malaspina
Journal:  Brain Commun       Date:  2021-07-09

8.  Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).

Authors:  Chae Kim; Tracy Haldiman; Krystyna Surewicz; Yvonne Cohen; Wei Chen; Janis Blevins; Man-Sun Sy; Mark Cohen; Qingzhong Kong; Glenn C Telling; Witold K Surewicz; Jiri G Safar
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

9.  Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.

Authors:  Chae Kim; Tracy Haldiman; Yvonne Cohen; Wei Chen; Janis Blevins; Man-Sun Sy; Mark Cohen; Jiri G Safar
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

10.  Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Ed M Choi; Michael D Geschwind; Camille Deering; Kristen Pomeroy; Amy Kuo; Bruce L Miller; Jiri G Safar; Stanley B Prusiner
Journal:  Lab Invest       Date:  2009-06       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.